1American Thoracic Society, European Respiratory Society. Internation-al muhidisciplinary consensus classification of the idiopathic intersti- tial pneumonias. Am J Respir Crit Care Med,2002,165 (2) :277.
2Ferguson MK, Litte L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortulity after pulmonary resection. J Thorac Cardiovasc Surg, 1998,96 (5) : 894 - 900.
1Schwars MI.Approach to the understanding,diagnosis,and management of interstitial lung disease.In interstitial Lung Disease.Editedby Schwarz Mand KingT Jr.Hamilton,ON;B.C.Decker,Inc,1998:3-30.
2Flaherty KR,Fernando JM.The role of pulmonary function testing in pulmonary fibrosis.Division of Pulmonary and Critical Care Medicine,Curr Opin Pulm Med,2000,6(5):404-410.
3Odonnell DE.Physiology of interstitial lung disease.In interstitial Lung Disease.Edited by Schwarz Mand King T Jr.Hamilton,ON;B.C.Decker,Inc,1998:51-70.
5Hughes JM,Bates DV.Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components.Respir Physiol Neurobiol,2003,138(2-3):115-142.
6Hsia CC.Cardiopulmonary limitations to exercise in restrictive lung disease. Med Sci Sports Exerc,1999,31(1 Suppl):S28-32.
7Wesolowski S,Kus J,Oniszh K,et al.Clinical presentation of own idiopathic pulmonary fibrosis patients according to international consensus statement,Pneumonol Alergol Pol,2001,69(11-12):635-643.
8Daniil ZD,Gilchrist FC,Nicholson AG,et al.A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.Am J Respir Crit Care Med,1999,160(3):899-905.
9Xaubet A,Agusti C,Luburich P,et al.Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis.AmJ Respir Crit Care Med,1998,158(2):431-436.
10Hubbard R,Johnston I,Britton J,et al.Survival in patients with cryptogenic fibrosing alveolitis.A population-based cohort study.Chest,1998,113(2):396-400.
1Masatsugu N,Toshihiro H,Mitsuko H,et al.Smoking history and underlying lung disease are associated with poor outcome in patients developinginterstitial pneumonia during low-dose amiodarone therapy[J].J Arrhyth,2013,29(1):5-8.
2Eugene J,Ruchira R.Bronchiolitis interstitial pneumonitis:a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis,with clinical correlation[J].Ann Diagnos Pathol,2008,12(3):171-180.
3Ganesh Raghu,Harold R. Collard,Jim J. Egan,Fern,o J. Martinez,Juergen Behr,Kevin K. Brown,Thomas V. Colby,Jean-Fran?ois Cordier,Kevin R. Flaherty,Joseph A. Lasky,David A. Lynch,Jay H. Ryu,Jeffrey J. Swigris,Athol U. Wells,Juli.An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. American Journal of Respiratory and Critical Care Medicine . 2011
